PHS
ARAV

PFM Health Sciences’s Aravive, Inc. Common Stock ARAV Stock Holding History

PFM Health Sciences’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-79,514
Closed -$8.76M – 114
2015
Q1 		$8.76M Sell
79,514
-65,397
-45% -$7.67M 0.24% 73
2014
Q4 		$19.5M Buy
144,911
+53,871
+59% +$6.3M 0.46% 58
2014
Q3 		$10.4M Buy
91,040
+28,135
+45% +$3.73M 0.24% 55
2014
Q2 		$10.6M Buy
+62,905
New +$10.9M 0.21% 59

Other funds holding ARAV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

PFM Health Sciences's ARAV Position: Q2 2015 in Review

PFM Health Sciences sold out of Aravive, Inc. Common Stock (ARAV) in Q2 2015, closing a stake of 79,514 shares — an estimated $8.76M sold.

PFM Health Sciences first reported a position in ARAV in Q2 2014 and held it in 4 quarters. The position peaked at $19.5M in Q4 2014. 66 funds tracked by Wall St. Rank hold ARAV as of Q2 2015.

  • PFM Health Sciences reported no remaining Aravive, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • PFM Health Sciences sold 79,514 Aravive, Inc. Common Stock shares in Q2 2015, an estimated $8.76M.
  • PFM Health Sciences first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
  • PFM Health Sciences's Aravive, Inc. Common Stock position peaked at $19.5M in Q4 2014.
  • 66 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q2 2015.

Based on PFM Health Sciences's 13F filing for Q2 2015, filed 14 Aug 2015.